ISG15 upregulation has been reported to promote cancer stem cell phenotype and increases cell resistance to cisplatin (DDP) treatment in nasopharyngeal carcinoma,11 while ISG15 downregulation increases cisplatin resistance in lung cancer.43 This evidence concerns the gene ISG15 and nasopharyngeal carcinoma.